124 related articles for article (PubMed ID: 8806961)
1. Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study.
Kennedy MM; Blessing K; King G; Kerr KM
Am J Dermatopathol; 1996 Jun; 18(3):273-7. PubMed ID: 8806961
[TBL] [Abstract][Full Text] [Related]
2. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?
Feinmesser M; Halpern M; Fenig E; Tsabari C; Hodak E; Sulkes J; Brenner B; Okon E
Hum Pathol; 1999 Nov; 30(11):1367-72. PubMed ID: 10571519
[TBL] [Abstract][Full Text] [Related]
3. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
Skirnisdóttir I; Sorbe B; Seidal T
Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
[TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
6. Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors.
Lai JH; Fleming KE; Ly TY; Pasternak S; Godlewski M; Doucette S; Walsh NM
Hum Pathol; 2015 Sep; 46(9):1290-6. PubMed ID: 26099430
[TBL] [Abstract][Full Text] [Related]
7. bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.
Ye D; Li H; Qian S; Sun Y; Zheng J; Ma Y
J Urol; 1998 Dec; 160(6 Pt 1):2025-8; discussion 2029. PubMed ID: 9817315
[TBL] [Abstract][Full Text] [Related]
8. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients.
Lê MG; Mathieu MC; Douc-Rasy S; Le Bihan ML; Adb El All H; Spielmann M; Riou G
Int J Cancer; 1999 Dec; 84(6):562-7. PubMed ID: 10567899
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
10. Analysis of bcl-2 in sporadic breast carcinoma.
Dueñas-González A; Abad-Hernández MM; Cruz-Hernández JJ; González-Sarmiento R
Cancer; 1997 Dec; 80(11):2100-8. PubMed ID: 9392332
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
12. Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.
Jansen RL; Joosten-Achjanie SR; Volovics A; Arends JW; Hupperets PS; Hillen HF; Schouten HC
Anticancer Res; 1998; 18(6A):4455-62. PubMed ID: 9891509
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2 and bcl-X in bladder cancer.
Kirsh EJ; Baunoch DA; Stadler WM
J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
[TBL] [Abstract][Full Text] [Related]
16. Alterations of p53 and Bcl-2 protein expression in the recurrent laryngeal and pharyngeal squamous cell carcinoma.
Rashad UM; Hussein MR; Algizawy SM
Am J Otolaryngol; 2011; 32(3):210-4. PubMed ID: 20434805
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
Lee WY; Jin YT; Tzeng CC
Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
[TBL] [Abstract][Full Text] [Related]
18. Low expression of bcl-2 in Brca1-associated breast cancers.
Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Murao S; Kunachak S; Maeda S
Cancer Lett; 2000 Nov; 160(2):199-208. PubMed ID: 11053650
[TBL] [Abstract][Full Text] [Related]
20. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
